Among these conditions, retinitis pigmentosa (RP) and age-related macular degeneration (AMD) are particularly prevalent. Recent advancements in gene therapy have opened new avenues for treating ...

The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...

BENGALURU: Bengaluru-based Narayana Nethralaya is developing gene therapy solutions that could drastically reduce the cost of ...

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

Researchers at Johns Hopkins and their collaborators conducted an open-label phase I clinical trial of a new treatment, in which a viral vector expressing the gene for sFLT01, a protein that ...

In this Healio Video Perspective from Retina 2025, Allen C. Ho, MD, discusses recent breakthroughs demonstrating that gene ...

The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

Aug. 24, 2022 — Researchers have developed a new gene therapy approach that shows promise for treating the dry form of Age Related Macular Degeneration (AMD) -- a progressive eye disease that ...

Fellow-KI researchers Anders Kvanta and Fredrik Lanner have been awarded a grant of SEK 10 million from the Promobilia ...

and Beam Therapeutics has resulted in a new base editing therapy for Stargardt disease, the most common form of inherited macular degeneration. Details of their work and the efficacy of the ...

Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration ... using a precise technique for gene correction. Stargardt disease ...

7, 2025 – A new light therapy device could be a game-changer for millions at risk of vision loss. The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration ...